Neuraxpharm gets a new private-equity owner

25 September 2020 - Deborah Wilkes

Premium

Germany’s Neuraxpharm will soon have a new private-equity owner. Permira has agreed to acquire the pharmaceutical company specialising in central nervous system (CNS) products from Apax Partners for an undisclosed sum.

Click tags below for more information on topics:

Neuraxpharm

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: